The Aporia
Warner, K. (2026, October 22). Abu Dhabi lures Eli Lilly, Oura, and Whoop in healthcare push. Semafor. https://www.semafor.com/article/10/22/2026/abu-dhabi-lures-eli-lilly-oura-and-whoop-in-healthcare-push
Warner, Kelsey. “Abu Dhabi lures Eli Lilly, Oura, and Whoop in healthcare push.” Semafor, 22 Oct. 2026, https://www.semafor.com/article/10/22/2026/abu-dhabi-lures-eli-lilly-oura-and-whoop-in-healthcare-push.
Warner, Kelsey. “Abu Dhabi lures Eli Lilly, Oura, and Whoop in healthcare push.” Semafor, October 22, 2026. https://www.semafor.com/article/10/22/2026/abu-dhabi-lures-eli-lilly-oura-and-whoop-in-healthcare-push.
Dated from the outlet's own feed. Check the original for its byline.
Abu Dhabi is investing heavily in preventive healthcare by partnering with US pharmaceutical giant Eli Lilly and wearable technology companies Whoop and Oura. During the Future Health Summit held this week, Mubadala Bio signed a deal with Eli Lilly to package and distribute GLP-1 drugs locally. Boston-based Whoop will study whether continuous monitoring can improve health markers like cholesterol in adults suffering from obesity and hypertension, which are significant public health issues in the Gulf region. Additionally, Oura launched Project Cradle, a two-year pilot project aimed at detecting spontaneous preterm birth using its ring technology, utilizing clinical and genomic records from Abu Dhabi’s healthcare system.